These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8262108)

  • 1. Circadian periodicity of urinary inhibitor of calcium oxalate crystallization in healthy Indians and renal stone formers.
    Singh RK; Bansal A; Bansal SK; Singh AK; Mahdi AA
    Eur Urol; 1993; 24(3):387-92. PubMed ID: 8262108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on circadian periodicity of serum and urinary urate in healthy Indians and renal stone formers.
    Singh RK; Bansal A
    Prog Clin Biol Res; 1987; 227B():305-13. PubMed ID: 3628342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronobiology of urinary citrate excretion amongst stone-formers and healthy males from north western India.
    Wangoo D; Thind SK; Gupta GS; Nath R
    Urol Res; 1991; 19(3):203-6. PubMed ID: 1887530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on crystalluria in calcium oxalate stone formers.
    Ahlstrand C; Tiselius HG; Larsson L
    Urol Res; 1984; 12(2):103-6. PubMed ID: 6539984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.
    Bek-Jensen H; Tiselius HG
    Urol Res; 1997; 25(5):365-72. PubMed ID: 9373919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
    Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian variations in the risk of urinary calcium oxalate stone formation.
    Robert M; Roux JO; Bourelly F; Boularan AM; Guiter J; Monnier L
    Br J Urol; 1994 Sep; 74(3):294-7. PubMed ID: 7953257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in circadian rhythmicity in calcium oxalate renal stone formers.
    Touitou Y; Touitou C; Charransol G; Reinberg A; Thomas J; Bogdan A; Barthelemy C; Desgrez P
    Int J Chronobiol; 1983; 8(3):175-92. PubMed ID: 6862698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule.
    Tiselius HG
    Urol Res; 1997; 25(2):153-9. PubMed ID: 9144885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of crystallization inhibitory activity of whole urine with a gel model.
    Li MK; Shum DK; Choi S
    Urol Res; 1987; 15(2):75-7. PubMed ID: 3590432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced inhibitory activity of uronic-acid-rich protein in urine of stone formers.
    Atmani F; Lacour B; Jungers P; Drüeke T; Daudon M
    Urol Res; 1994; 22(4):257-60. PubMed ID: 7871640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
    Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
    Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of urinary macromolecules on aggregation of calcium oxalate in recurrent calcium stone formers and healthy.
    Ebisuno S; Kohjimoto Y; Yoshida T; Ohkawa T
    Urol Res; 1993; 21(4):265-8. PubMed ID: 8212414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary supersaturation with respect to brushite in patients suffering calcium oxalate lithiasis.
    Berland Y; Boistelle R; Olmer M
    Nephrol Dial Transplant; 1990; 5(3):179-84. PubMed ID: 2113644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary inhibitory activity of calcium oxalate monohydrate crystal growth in stone-formers & non stone-formers.
    Sidhu H; Vaidyanathan S; Wangoo D; Rattan V; Thind SK; Nath R; Malakondaiah GC; Tandon SP
    Indian J Med Res; 1987 Oct; 86():500-5. PubMed ID: 3443483
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effect of bikunin on calcium oxalate crystallization in vitro and urinary bikunin decrease in renal stone formers.
    Médétognon-Benissan J; Tardivel S; Hennequin C; Daudon M; Drüeke T; Lacour B
    Urol Res; 1999; 27(1):69-75. PubMed ID: 10092156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.